Consideration of the adaptive randomization allocation ratio in the presence of treatment group heteroscedasticity in clinical trials
Journal Article
·
· Journal of Biopharmaceutical Statistics
- Department of Statistics, University of Pittsburgh, Pennsylvania, United States
- Division of Biometrics IX, Office of Biostatistics, US Food and Drug Administration Center for Drug Evaluation and Research, Maryland, United States
Not provided.
- Research Organization:
- Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- SC0014664
- OSTI ID:
- 1982425
- Journal Information:
- Journal of Biopharmaceutical Statistics, Vol. 32, Issue 3; ISSN 1054-3406
- Publisher:
- Taylor & Francis
- Country of Publication:
- United States
- Language:
- English
Similar Records
Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer
Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
Journal Article
·
2021
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:23198572
+3 more
Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report
Journal Article
·
1988
· J. Clin. Oncol.; (United States)
·
OSTI ID:6745526
+7 more
Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
Journal Article
·
1985
· N.Engl. J. Med.; (United States)
·
OSTI ID:5834416
+7 more